MultiVir Eyes Float Amid Stream Of Cancer-Focused IPOs
Texas-based MultiVir Inc., which is developing gene therapies to treat cancer, outlined plans Monday to launch an initial public offering on the Nasdaq, just days after cancer immunotherapy developer Cellectis SA...To view the full article, register now.
Already a subscriber? Click here to view full article